| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| V V Neroev, N B Chesnokova, T D Okhotsimskaya, M V Ryabina, V A Fadeeva, T А Pavlenko, O V Bezno. [The effect of intravitreally administered angiogenesis inhibitor on the concentration of angiotensin-converting enzyme in the blood serum and lacrimal fluid in patients with diabetic macular edema]. Problemy endokrinologii. vol 65. issue 2. 2021-08-25. PMID:31271708. |
diabetic retinopathy (dr) is one of the more serious complications of diabetes and the main cause of blindness among working-age individuals. |
2021-08-25 |
2023-08-13 |
Not clear |
| Tian Niu, Junwei Fang, Xin Shi, Mengya Zhao, Xindan Xing, Yihan Wang, Shaopin Zhu, Kun Li. Pathogenesis Study Based on High-Throughput Single-Cell Sequencing Analysis Reveals Novel Transcriptional Landscape and Heterogeneity of Retinal Cells in Type 2 Diabetic Mice. Diabetes. vol 70. issue 5. 2021-08-24. PMID:33674409. |
diabetic retinopathy (dr) is the leading cause of acquired blindness in middle-aged people. |
2021-08-24 |
2023-08-13 |
mouse |
| Yuan-Yuan Yu, Qiu-Ping Liu, Meng-Ting Li, Pei An, Yu-Ying Chen, Xin Luan, Chao Lv, Hong Zhan. Hu-Zhang-Qing-Mai-Yin Inhibits Proliferation of Human Retinal Capillary Endothelial Cells Exposed to High Glucose. Frontiers in pharmacology. vol 12. 2021-08-24. PMID:34421625. |
diabetic retinopathy (dr) is one of the serious complications of diabetes and an important cause of blindness. |
2021-08-24 |
2023-08-13 |
human |
| Irini Chatziralli, Sara Touhami, Maria Vittoria Cicinelli, Chrysa Agapitou, Eleni Dimitriou, George Theodossiadis, Panagiotis Theodossiadi. Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy. Eye (London, England). 2021-08-19. PMID:34408316. |
diabetic retinopathy (dr) is the most common microvascular complication of diabetes mellitus (dm) and the leading cause of blindness in patients with dm. |
2021-08-19 |
2023-08-13 |
Not clear |
| Zhan Wu, Gonglei Shi, Yang Chen, Fei Shi, Xinjian Chen, Gouenou Coatrieux, Jian Yang, Limin Luo, Shuo L. Coarse-to-fine classification for diabetic retinopathy grading using convolutional neural network. Artificial intelligence in medicine. vol 108. 2021-08-18. PMID:32972665. |
diabetic retinopathy (dr) is the most common eye complication of diabetes and one of the leading causes of blindness and vision impairment. |
2021-08-18 |
2023-08-13 |
human |
| Huan-Ran Zhou, Hong-Yu Kuan. Circular RNAs: Novel target of diabetic retinopathy. Reviews in endocrine & metabolic disorders. vol 22. issue 2. 2021-08-16. PMID:33761053. |
in diabetic patients, diabetic retinopathy (dr) is the leading cause of blindness and seriously affects the quality of life. |
2021-08-16 |
2023-08-13 |
Not clear |
| Rehab E Abo El Gheit, Nema A Soliman, Ghada A Badawi, Nermin M Madi, Mervat H El-Saka, Shimaa M Badr, Marwa N Ema. Retinoprotective effect of agmatine in streptozotocin-induced diabetic rat model: avenues for vascular and neuronal protection : Agmatine in diabetic retinopathy. Journal of physiology and biochemistry. vol 77. issue 2. 2021-08-06. PMID:33635523. |
diabetic retinopathy (dr) is the most common diabetic neurovascular complication, and the leading cause of preventable blindness among working-age individuals. |
2021-08-06 |
2023-08-13 |
rat |
| Guodan Liu, Shifeng Zhou, Xinge Li, Xuchen Ding, Miao Tia. Inhibition of hsa_circ_0002570 suppresses high-glucose-induced angiogenesis and inflammation in retinal microvascular endothelial cells through miR-1243/angiomotin axis. Cell stress & chaperones. vol 25. issue 5. 2021-08-04. PMID:32319024. |
diabetic retinopathy (dr) is the most severe microvascular complication of diabetes and a major cause of visual impairment and blindness. |
2021-08-04 |
2023-08-13 |
human |
| Bing-Yan Li, Wei Tan, Jing-Ling Zou, Yan He, Shigeo Yoshida, Bing Jiang, Ye-Di Zho. Role of interferons in diabetic retinopathy. World journal of diabetes. vol 12. issue 7. 2021-07-31. PMID:34326947. |
diabetic retinopathy (dr) is one of the major causes of visual impairment and irreversible blindness in developed regions. |
2021-07-31 |
2023-08-13 |
human |
| Yong Yu, Kai-Ming Ren, Xiao-Long Che. Expression and role of P-element-induced wimpy testis-interacting RNA in diabetic-retinopathy in mice. World journal of diabetes. vol 12. issue 7. 2021-07-31. PMID:34326959. |
as one of the major microvascular complications of diabetes, diabetic retinopathy (dr) is the leading cause of blindness in the working age population. |
2021-07-31 |
2023-08-13 |
mouse |
| Lijie Dong, Zhe Zhang, Xun Liu, Qiong Wang, Yaru Hong, Xiaorong Li, Juping Li. RNA sequencing reveals BMP4 as a basis for the dual-target treatment of diabetic retinopathy. Journal of molecular medicine (Berlin, Germany). vol 99. issue 2. 2021-07-30. PMID:33188599. |
diabetic retinopathy (dr), currently considered as a neurovascular disease, has become the major cause of blindness. |
2021-07-30 |
2023-08-13 |
Not clear |
| Gao Jinfeng, Sehrish Qummar, Zhang Junming, Yao Ruxian, Fiaz Gul Kha. Ensemble Framework of Deep CNNs for Diabetic Retinopathy Detection. Computational intelligence and neuroscience. vol 2020. 2021-07-28. PMID:33381160. |
dr causes blurred vision or it may lead to blindness if it is not detected in early stages. |
2021-07-28 |
2023-08-13 |
Not clear |
| Jie-Hong Wu, Ya-Nan Li, An-Qi Chen, Can-Dong Hong, Chun-Lin Zhang, Hai-Ling Wang, Yi-Fan Zhou, Peng-Cheng Li, Yong Wang, Ling Mao, Yuan-Peng Xia, Quan-Wei He, Hui-Juan Jin, Zhen-Yu Yue, Bo H. Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy. EMBO molecular medicine. vol 12. issue 2. 2021-07-27. PMID:31943789. |
diabetic retinopathy (dr) is a common complication of diabetes and leads to blindness. |
2021-07-27 |
2023-08-13 |
Not clear |
| Ying Cheng, Liyuan Peng, Xiaoqing Deng, Ting Li, Hang Guo, Chaofei Xu, Ting Fang, Xiaohuan Liu, Bei Sun, Liming Che. Prostaglandin F2α protects against pericyte apoptosis by inhibiting the PI3K/Akt/GSK3β/β-catenin signaling pathway. Annals of translational medicine. vol 9. issue 12. 2021-07-20. PMID:34277821. |
diabetic retinopathy (dr) is the most common microvascular complication of diabetes and the main cause of non-traumatic blindness in adults. |
2021-07-20 |
2023-08-13 |
Not clear |
| Karen Frudd, Sobha Sivaprasad, Rajiv Raman, Subramanian Krishnakumar, Yeddula Rebecca Revathy, Patric Turowsk. Diagnostic circulating biomarkers to detect vision-threatening diabetic retinopathy: Potential screening tool of the future? Acta ophthalmologica. 2021-07-16. PMID:34269526. |
diabetic retinopathy (dr) is currently one of the leading causes of blindness in working-age adults worldwide. |
2021-07-16 |
2023-08-13 |
Not clear |
| Salma El-Sayed Radwan, Amal El-Kamel, Eiman I Zaki, Susi Burgalassi, Erica Zucchetti, Riham M El-Mosleman. Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy. International journal of nanomedicine. vol 16. 2021-07-14. PMID:34239300. |
apatinib (apa) is a novel anti-vascular endothelial growth factor with the potential to treat diabetic retinopathy (dr); a serious condition leading to visual impairment and blindness. |
2021-07-14 |
2023-08-13 |
cattle |
| Wenjun Zou, Shasha Luo, Zhengwei Zhang, Libo Cheng, Xiaoli Huang, Nannan Ding, Ying Pan, Zhifeng W. ASK1/p38‑mediated NLRP3 inflammasome signaling pathway contributes to aberrant retinal angiogenesis in diabetic retinopathy. International journal of molecular medicine. vol 47. issue 2. 2021-07-12. PMID:33416127. |
diabetic retinopathy (dr) is the leading cause of blindness among the working‑age population in several countries. |
2021-07-12 |
2023-08-13 |
human |
| Annagrazia Adornetto, Carlo Gesualdo, Maria Luisa Laganà, Maria Consiglia Trotta, Settimio Rossi, Rossella Russ. Autophagy: A Novel Pharmacological Target in Diabetic Retinopathy. Frontiers in pharmacology. vol 12. 2021-07-09. PMID:34234681. |
diabetic retinopathy (dr) is a serious complication of diabetes mellitus representing the main preventable cause of acquired blindness worldwide. |
2021-07-09 |
2023-08-13 |
Not clear |
| Ning Guo, Ayinu Nulahou, Qian Bu, Meng Liu, Yan Wang, Yong Zhao, Lei Yang, Yunxian Ga. MiR-542-5p regulates the progression of diabetic retinopathy by targeting CARM1. Acta biochimica Polonica. vol 67. issue 3. 2021-07-07. PMID:32870623. |
diabetic retinopathy (dr), as the most frequent microvascular complication of diabetes mellitus (dm), causes vision loss and blindness in adults worldwide with increasing incidence. |
2021-07-07 |
2023-08-13 |
Not clear |
| Hui-Yao Li, Yue Yuan, Yu-Hong Fu, Ying Wang, Xin-Yuan Ga. Hypoxia-inducible factor-1α: A promising therapeutic target for vasculopathy in diabetic retinopathy. Pharmacological research. vol 159. 2021-07-06. PMID:32464323. |
diabetic retinopathy (dr) is a serious condition that can cause blindness in diabetic patients. |
2021-07-06 |
2023-08-13 |
Not clear |